Ignite Creation Date:
2024-05-06 @ 7:45 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06125223
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-11-09
First Post:
2023-10-31
Brief Title:
PABLIXIMAB as Neoadjuvant Therapy for Head and Neck Squamous-cell Carcinoma
Sponsor:
Xijing Hospital
Organization:
Xijing Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-11-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-31
First Submit QC Date:
November 5 2023
Study First Post Date:
2023-11-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-05
Last Update Post Date:
2023-11-09
Last Update Post Date Type:
ACTUAL